
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients
Keywords: اثر; Multiple sclerosis; CNS demyelination; Autoimmunity interferon; Dosage; Efficacy; Cytokines; Inflammatory gene expression; Signaling; Signal transducers and activators of transcription STAT; Nuclear factor kappa-B (NF-κB); Peripheral immune cells; EAE/TM